Mother of child who has hip surgery calls for confirmation if surgery was required
The mother of a child on whom bilateral hip surgery was performed is calling for reassurance for parents and confirmation from hospitals about whether surgery was required.
Áine Gladney-Knox, a Sinn Féin candidate for the Carlow-Kilkenny constituency in the last general election, told RTÉ radio's Morning Ireland that her son Archie was diagnosed with hip dysplasia when he was six months old and had bilateral pelvic operation in Crumlin hospital on the 19th of April 2022.
Advertisement
Post surgery Archie had to be readmitted to hospital and undergo a blood transfusion and further surgery. 'He just screamed and screamed and screamed. That child went through absolute hell.
"He really, really went through a horrendous time and we didn't actually get home (from hospital) till the 4th of May.'
Ms Gladney-Knox said the last time Archie had an appointment was 'a year and a half ago' with no further appointment. 'They said as far as they were concerned that they were happy and they were going to leave him for a few years.'
Recently the family received a letter from Children's Health Ireland saying that an audit was being carried out on cases of hip dysplasia surgeries.
Advertisement
'The letter for me was a bit wishy washy because I seen the letter and I just presumed it was like an audit they were doing on children, like it didn't break down what had actually happened.'
Ms Gladney-Knox said she went about her day and it wasn't until she heard about the issue from Pearse Doherty that she went back home, looked at the letter again and realised that Archie was one of those children.
'And that's when I actually sat at my kitchen table and cried my eyes out because I was like, if he is one of the children, after what he's after going through, like it would actually break me as a parent.
Ireland
Politics watch: Government criticised ahead of chi...
Read More
'As a parent, you trust what they're telling you and you listen to what the doctors are saying and you go with what they recommend and that was it and it wasn't until this, now we're like, we still haven't heard a word from anybody, only this letter.
Advertisement
'I'm coming home every day checking my letter box to see if there is an update. Is Archie one of these children? It's eating up every day here in this house.'
Ms Gladney-Knox said she was not at all reassured by the letter, if anything, it had made her more anxious. It had raised more questions and made her question herself and her judgement as a parent. 'We really need these answers. This has been a kick in the teeth. We want to know how long this is going to take. I want answers for my child.
'They have to get this right for all the families and all the children that are involved.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
7 minutes ago
- Daily Mail
EXCLUSIVE Warning over hair loss cream used by millions after doctors discover freaky side effect
Doctors have issued a warning about hair growth treatment minoxidil after a woman grew a beard. The 28-year-old reported using hair growth spray minoxidil to treat her hair loss caused by alopecia, suffered by 7million Americans that causes hair loss. Patients apply the medication, sold as a spray or foam, to the scalp and leave it in to absorb. However, the unnamed woman wore a wig during the day and cap at night, which causes the drug to be absorbed at much higher levels in her blood. It then traveled elsewhere in her body, causing uncontrollable hair growth in her face, arms and legs. Doctors say the 40million Americans who take the drug should be aware of the risks of wearing tight caps while taking it. Minoxidil, sold in the US under brand name Rogaine, is applied to the scalp to stimulate hair growth. It costs around $60 for a six-month supply. Doctors writing in as medical journal said: 'Exceeding this dose does not improve efficacy but significantly increases the risk of systemic absorption and adverse effects.' The FDA approved safe dose of the spray, which the woman used, is one milliter twice per day, or six sprays. While side effects are usually minor, such as scalp irritation or changes in hair texture or color, the drug has been linked to excess hair growth and loss. The woman in the case report was diagnosed with androgenetic alopecia, a form of hair loss caused by genetic predisposition or an imbalance of hormones like estrogen and androgens. Prior to treatment, the woman, from France, had a large bald spot on the top of her head. She had mild anemia and vitamin D, both of which can deprive hair follicles of oxygen and cause hair loss, but had no other health issues. Along with vitamin D and zinc supplements, she used five percent minoxidil spray twice a day for two months. She also had done three monthly sessions of LED therapy and plasma-rich plasma injections (PRP), which are meant to separate plasma from the blood and inject it back into the scalp. Plasma is rich in platelets, which have growth factors. After two months of minoxidil treatment, she returned to doctors with increased hair growth on her face, arms and legs. Doctors found wearing a wig during the day and a tight cap at night after applying minoxidil left the woman's scalp 'constantly occluded, day and night.' This means her scalp was constricted and hair follicles became blocked, leading the body to absorb higher amounts of minoxidil than if her hair follicles were still open. The doctors believe this lead to 'systemic absorption' of the drug and effectively a higher than safe dose. The experts wrote: 'Minoxidil is an effective treatment but can occasionally lead to hypertrichosis, especially when applied in high concentrations or over large areas of the body. 'This case illustrates the critical need for precise patient instruction on the correct application of topical therapies to prevent adverse systemic effects such as hypertrichosis.' The woman had laser hair removal on her face and stopped taking minoxidil. She continued with her other treatments.
The Independent
21 minutes ago
- The Independent
Wrong embryo implanted in second such IVF clinic mix-up
Monash IVF, a top Australian IVF provider, mistakenly implanted a patient with her own embryo instead of her partner's at a Melbourne clinic on June 5. This is the second such mix-up for Monash IVF, following an April disclosure of a similar incident in Brisbane in 2023, raising concerns about industry oversight. The company stated it is supporting the couple involved and has extended an existing independent investigation and is installing extra verification safeguards. Shares of Monash IVF have dropped 25 per cent following the incident, and analysts predict potential reputational damage and market share losses. Victorian health minister Mary-Anne Thomas has deemed the incident "completely unacceptable" and confirmed that the Victorian Department of Health is investigating the company.
The Independent
an hour ago
- The Independent
Rare cancer with nonspecific symptoms increasing among millennials
A study published in Annals of Internal Medicine indicates a surprising increase in appendix cancer rates among Millennials and Generation X, suggesting a higher disease burden in younger generations. The study assessed data from 4,858 patients diagnosed with appendix cancer between 1975 and 2019, categorising them into five-year age groups to understand how the risk evolved over the years. Compared to the 1945 birth cohort, the incidence of appendix cancer more than tripled in individuals born around 1980 and quadrupled by the birth cohort of 1985. Researchers suggest that environmental, lifestyle, and genetic factors intensified after World War II, such as dietary patterns, gut bacteria alterations, and gastrointestinal inflammation, may explain the increase. The study calls for more research, particularly involving genomics data, to uncover the mechanisms driving this trend and urges physicians to revisit screening protocols and develop early detection biomarkers.
